baber/WOPTO huggingface dataset:
Patent AU-2018329846-B2 (AU)
Title: Processes and systems for metabolite production using hydrogen rich C1-containing substrates
Inventor: Conrado Robert John
IPC: C12P5/02
Filed: 2018-09-06
Granted: 2024-01-11
Abstract: The invention is directed to a process for producing one or more fermentation product in a multi-stage process including an inoculation reactor and at least one bioreactor. The inoculation reactor is fed a C1-containing gaseous substrate containing a reduced amount of hydrogen. The hydrogen is reduced to increase the proportion of CO in the C1-containing gaseous substrate being provided to the inoculation reactor. The inoculation reactor ferments the CO-rich C1-containing gaseous substrate and produces an inoculum, which is fed to at least one bioreactor. The bioreactor receives the C1-containing gaseous substrate, which may or may not contain reduced amounts of hydrogen, to produce one or more fermentation product. By providing a CO-rich C1-containing gaseous substrate to the inoculation reactor, both the inoculation reactor and the subsequent bioreactor(s), are able to have increased stability and product selectivity.
Patent AU-2018369241-B2 (AU)
Title: Pharmaceutical preparation having excellent photostability and drug release properties
Inventor: HAYASHI NAOMI
IPC: G01N30/88
Filed: 2018-11-15
Granted: 2023-01-05
Abstract: The present invention provides a preparation which remains substantially uncolored even when irradiated with light, by coating a preparation containing the compound represented by formula (I), a salt of said compound, or a crystal of these compounds with a photostable substance and a polymer molecule, using, in particular, at least one substance from among titanium oxide and talc as the photostable substance and hypromellose as the polymer molecule.
Patent AU-2018373022-B2 (AU)
Title: Using discomfort for speed planning for autonomous vehicles
Inventor: KUNZ TOBIAS
IPC: B60W40/105
Filed: 2018-11-20
Granted: 2021-04-22
Abstract: Aspects of the disclosure relate to controlling a first vehicle (100) in an autonomous driving mode. While doing so, a second vehicle (720, 820, 920, 1020) may be identified. Geometry for a future trajectory of the first vehicle may be identified, and an initial allowable discomfort value may be identified. Determining a speed profile for the geometry that meets the value may be attempted by determining a discomfort value for the speed profile based on a set of factors relating to at least discomfort of a passenger of the first vehicle and discomfort of a passenger of the second vehicle. When a speed profile that meets the value cannot be determined, the value may be adjusted until a speed profile that meets the value is determined. The speed profile that meets an adjusted value is used to control the first vehicle in the autonomous driving mode.
Patent AU-2018383962-B2 (AU)
Title: Pre-flush unit for carrying out a pre-flush procedure in a breathing gas circuit of a recirculating breathing protection apparatus
Inventor: WENDEROTH KURT
IPC: A61M16/08
Filed: 2018-11-19
Granted: 2021-09-30
Abstract: The present invention relates to a pre-flush unit (10) for carrying out a pre-flush procedure in a breathing gas circuit (210) of a recirculating breathing protection apparatus (200), having a main body (20) with an inlet port (22) for the supply of breathing gas from a breathing gas reservoir (220) and with an outlet port (24) for the removal of breathing gas to the breathing gas circuit (210), wherein the inlet port (22) and the outlet port (24) are fluidically connected via a flow section (32) of a valve chamber (30) in the main body (20), and in the valve chamber (30) there is arranged a valve body (40) with a sealing face (42), the valve chamber (30) also containing an elastomer body (50) with a counter-sealing face (52) that separates the flow section (32) from a control section (34) in a fluid-tight manner and that consists of an elastic material which presses the counter-sealing face (52) against the sealing face (42) of the valve body (40) with a sealing force so as to seal the flow section (32), wherein moreover the main body (20) has a control port (26) for the controlled supply of breathing gas from the breathing gas reservoir (220) to the control section (34) for the purpose of pressure equalization between the flow section (32) and the control section (34).
Patent AU-2019201687-B2 (AU)
Title: Network device vulnerability prediction
Inventor: TIWARI SANJAY
IPC: G06F17/00
Filed: 2019-03-12
Granted: 2020-10-22
Abstract: A system including a processor configured to detect an outage of a network 
device, determining the outage of the network device is an actual outage based on an 
indication that a human confirmed the outage of the network device was an actual 
outage, predict a vulnerability of the network device based on a survival analysis, and 
cause the vulnerability of the network device to be displayed.
Patent Application for: NETWORK DEVICE VULNERABILITY PREDICTION 
Inventor(s): Sanjay Tiwari et a 
Attorney Docket No.: 15718-311 
1/22 
------------------
3Co"- IM 
- -1 
o 
00 
CDI 
1=5
Patent AU-2019226212-B2 (AU)
Title: Combination of Pl3K inhibitor and c-Met inhibitor
Inventor: CAPONIGRO GIORDANO
IPC: A61K31/4745
Filed: 2019-09-05
Granted: 2020-05-14
Abstract: :\dar\nterwovn\NRPortbl\DCC\DAR\1666595_l.docx-9/03/2018 Abstract The present invention relates to a pharmaceutical combination which comprises (a) a phosphatidylinositol 3-kinase inhibitor or pharmaceutically acceptable salt thereof, and (b) at least one c-Met receptor tyrosine kinase inhibitor or pharmaceutically acceptable salt thereof, for simultaneous, separate or sequential administration for the treatment of a proliferative disease, particularly a c-Met dependent proliferative disease; a pharmaceutical composition comprising such combination; a method of treating a subject having a proliferative disease comprising administration of said combination to a subject in need thereof; use of such combination for the treatment of proliferative disease; and a commercial package comprising such combination.
Patent AU-2019308251-B2 (AU)
Title: Low force valves for drug delivery pumps
Inventor: MCLAUGHLIN IAN
IPC: F04B7/00
Filed: 2019-07-17
Granted: 2023-05-18
Abstract: Disclosed are examples of valve systems and methods of operating the respective valve systems. An example valve system may include a valve body, an inlet component, an outlet component and a valve tube. The valve body may include a first void and a second void. The inlet component may be coupled to the first void and the outlet component may be coupled to the second void. The valve tube may include a side port and may be positioned through the valve body and coupled to the first void, the inlet component, the second void, and the outlet component. Other valve system examples may include including a valve body, a first septum, a second septum, a first piston, a second piston and a tube. The disclosed methods describe the interaction of the respective components of the respective valve system example.
Patent AU-2019343597-B2 (AU)
Title: Forward osmosis membrane and membrane module including same
Inventor: INOUE FUMIYOSHI
IPC: D01F1/08
Filed: 2019-09-18
Granted: 2022-09-15
Abstract: Provided are a composite forward osmosis membrane and a membrane module including same. The composite forward osmosis membrane reduces salt back-diffusion and has high water-permeability, or is made of readily available materials and can be easily manufactured. Even when used at high pressure, separation between a substrate membrane support layer and a separation active layer does not occur in the composite forward osmosis membrane, and thus the composite forward osmosis membrane exhibits stable high performance. This composite forward osmosis membrane is composed of a hollow-strand porous polymer substrate membrane, wherein a separation active layer is present on the inner surface or outer surface of the substrate membrane, an inner columnar void layer having a predetermined shape is present at a predetermined thickness with respect to the thickness of the substrate membrane from the inner surface toward the center of the substrate membrane, and an outer columnar void layer is present at a predetermined thickness with respect to the thickness of the membrane from the outer surface toward the center of the substrate membrane. The substrate membrane has a water permeability F1 within a predetermined range and a rejection ratio R within a predetermined range, or the substrate membrane support layer contains a polyether sulfone having an OH group. The membrane has a thickness within a predetermined range and a compression strength within a predetermined range.
Patent AU-2020261961-B2 (AU)
Title: Human PD-L1 antibodies
Inventor: FANG LEI
IPC: G01N33/68
Filed: 2020-04-26
Granted: 2022-07-07
Abstract: Provided are full human anti-PD-L1 antibodies or fragments thereof. In various examples, the antibodies or fragments thereof include a VH CDR1, a VH CDR2, a VH CDR3, a VL CDR1, a VL CDR2, and a VL CDR3 which are selected from sequence groups of SEQ ID NO: 35-42, SEQ ID NO: 43-51, SEQ ID NO: 52-66, SEQ ID NO: 67-79, SEQ ID NO:80-88 and SEQ ID NO: 89-102, respectively, or variants of each thereof. Methods of using the antibodies or fragments thereof for treating and diagnosing diseases such as cancer and infectious diseases are also provided.
Patent AU-2020284371-B2 (AU)
Title: Detonation energy absorption device and vehicle equipped with same
Inventor: LEHMANN KEVIN
IPC: F41H7/04
Filed: 2020-05-04
Granted: 2023-09-28
Abstract: The invention relates to an energy absorption device (100) for protecting a vehicle element (10, 10', 10"), in particular a military vehicle (1, 1', 1"), from a detonation impact, comprising a first securing element (110) which can be connected to a vehicle chassis (2) and/or a vehicle hull (2) and comprising a second securing element (120) which can be connected to the vehicle element (10, 10', 10") to be protected, wherein at least two webs (130, 140, 150, 160) are arranged between the first and the second securing element (110, 120). The at least two webs (130, 140, 150, 160) are arranged so as to lie one over the other on a common plane (E).
Patent AU-2020352751-B2 (AU)
Title: Composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for improvement of the quality of visual performance including contrast sensitivity in persons in need of such an improvement, including persons suffering from at least one eye disease, particularly vitreous floaters
Inventor: NOLAN JOHN
IPC: A23L33/105
Filed: 2020-09-24
Granted: 2023-08-17
Abstract: The subject-matter of the invention is a composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for the improvement of the quality of visual performance including contrast sensitivity in persons in need of such an improvement, including persons suffering from at least one eye disease, particularly vitreous floaters. The composition of the dietary supplement and/or of nutritional additive for food according to the invention comprises as active substances L-lysine, vitamin C, zinc, grape extract and bitter orange extract in therapeutically effective quantities, and optionally at least one excipient. In the preferred embodiment of said composition, the percentages of the individual active substances relative to the sum of the percentages of all active substances are about 50% by weight of L-lysine, about 15% by weight of vitamin C, about 2% by weight of zinc, about 10% by weight of the grape extract and about 23% by weight of the bitter orange extract, with all percentages of the individual active substances adding up to 100% by weight of all active substances.
Patent AU-2020380339-B2 (AU)
Title: Tensioning device and driven member thereof
Inventor: SQUIRES TIMOTHY P
IPC: B25B25/00
Filed: 2020-11-05
Granted: 2022-07-07
Abstract: A tensioning device includes a housing, a drive member, an inner sleeve and a driven member. The housing includes a first attachment feature. The driven member includes a second attachment feature. The inner sleeve is disposed at least partially in the housing and is rotatably coupled with the housing. The drive member is rotatably coupled with the housing and is operably coupled with the inner sleeve such that rotation of the drive member facilitates rotation of the inner sleeve. The driven member is movable with respect to the guide member between a retracted position and an extended position along a centerline.
Patent AU-2020387750-B2 (AU)
Title: Magnetic tracer compositions
Inventor: BARTLETT STEWART GAVIN
IPC: A61K49/12
Filed: 2020-11-20
Granted: 2021-10-21
Abstract: Disclosed herein are pharmacologically acceptable magnetic nanoparticles suitable for administration to a subject. The magnetic nanoparticles have a pharmacologically acceptable polymer composition coating. The polymer composition coating comprises a polymeric steric stabiliser that promotes dispersion of the magnetic nanoparticles in a liquid, the polymeric steric stabiliser comprising (i) an anchoring polymer segment having one or more binding group that bind the polymeric steric stabiliser to the magnetic nanoparticles, and (ii) a steric stabilising polymer segment. The polymer composition coating also comprises:a polymeric targeting moiety comprising (i) an anchoring polymer segment having one or more binding group that bind the polymeric targeting moiety to the magnetic nanoparticles, and (ii) one or more targeting group for selectively targeting specific sites in the subject upon administration of the dispersion; and optionally a polymeric luminescent moiety comprising (i) an anchoring polymer segment having one or more binding group that bind the polymeric luminescent moiety to the magnetic nanoparticles, and (ii) one or more luminescent group for emitting light or an acoustic signal in response to light that enables in vivo location visualisation of the nanoparticles.
Patent AU-2021203779-B2 (AU)
Title: Modified capsid proteins for enhanced delivery of parvovirus vectors
Inventor: SAMULSKI RICHARD JUDE
IPC: A61K35/76
Filed: 2021-06-08
Granted: 2022-08-18
Abstract: 500 50000 
50i 500 
rAAV1 rAAV1 T265D rAAV1Fr265E rAAV1 T265F rAAV1,T265DEI 
106 
0 ~106: 
FIG. IA 
This invention relates to modified parvovirus capsid proteins with enhanced 
transduction efficiency, viral vectors comprising the same, and methods of using the 
same for delivery of nucleic acids to a cell or a subject.
Patent AU-2021218059-B2 (AU)
Title: Lordotic expandable fusion implant
Inventor: STEIN CHRIS
IPC: A61F2/30
Filed: 2021-08-18
Granted: 2022-11-24
Abstract: An expandable spinal implant comprising a plurality of moveable endplates pivotably 
connected to a housing is provided. An expandable spinal implant comprising a plurality of 
moveable endplates pivotably connected to a housing, a central body, a lead screw engaged 
with the central body and a passive locking mechanism is also provided.
Patent AU-2021229207-B2 (AU)
Title: Lidar apparatus with rotatable polygon deflector having refractive facets
Inventor: GALLOWAY RYAN MOORE
IPC: G01S7/484
Filed: 2021-09-09
Granted: 2022-12-01
Abstract: Atty. Dkt. No. 120261-1085 (F1051WOO) 
ABSTRACT 
A LIDAR apparatus can include a polygon deflector that includes a plurality of facets. The 
LIDAR apparatus can include a motor rotatably coupled to the polygon deflector. The motor is 
configured to rotate the polygon deflector about a first axis orthogonal to a first plane. The 
LIDAR apparatus can include an optic positioned within an interior of the polygon deflector.  
The optic collimates a first beam to be incident on a particular facet of the plurality of facet. The 
particular facet of the plurality of facets refracts the first beam in the first plane between a first 
angle and a second angle as the polygon deflector rotates about the first axis to output a second 
beam.  
-41
51-0309-8286.1
Patent AU-2021249482-B2 (AU)
Title: Switchable amplifier
Inventor: PÉREZ DE AYALA RULL PEDRO
IPC: G01R31/28
Filed: 2021-04-02
Granted: 2023-09-07
Abstract: In order to provide a simple and robust voltage amplifier and current amplifier for a test device (10) for testing an electrical component, an amplifier (8) is designed to output a test signal at a signal output between a positive output connection (P) and a negative output connection (N), wherein the amplifier comprises a first half bridge (HB1) and a second half bridge (HB2), wherein a switch unit (7) is provided, which is designed to switch the first half bridge (HB1) and the second half bridge (HB2) in parallel with the signal output in a first operating mode (Mi) and to switch the first half bridge (HB1) and the second half bridge (HB2) in series with the signal output in a second operating mode (Mu).
Patent JP-3578335-B2 (JP)
IPC: H01L23/36
Filed: 2000-11-20
Granted: 2004-10-20
Abstract: PROBLEM TO BE SOLVED: To provide a power semiconductor device which is superior in practical use because of a wide selective range of heat sink materials and easy to manufacture and superior in recycling, and can realize superior radiation characteristics. SOLUTION: A semiconductor module 100 having a power semiconductor element chip and radiation metal plates disposed on both sides of the chip is mounted on a heat sink 110, and a pressure holder 112 presses the radiation metal plate at the opposite side of the module 100 to thereby press the radiation metal plate at the heat sink side of the module 100 to the heat sink 100 surface.
Patent JP-4331891-B2 (JP)
IPC: C12Q1/56
Filed: 1999-02-01
Granted: 2009-09-16
Abstract: A method of determining the coagulation potential of a plasma sample be pre-incubating the plasma sample with a reagent such that endogenous protein C in the plasma is at least partially converted into activated protein C by the reagent, adding factor Xa which is progressively inactivated by antithrombin III/heparin cofactor 2 during the preincubation, adding an exogenous reagent which activates factor X to Xa or prothrombin to thrombin in a factor V-dependent manner, monitoring a reaction indicative of the rate of coagulation of the plasma sample, comparing that rate of coagulation control, or the equivalent rate determined for an individual without impaired coagulation control, or the equivalent rate determined for the plasma sample in the absence of protein C activator, and determining the coagulation potential of the plasma sample from one or other of the compairsons.
Patent JP-4499282-B2 (JP)
IPC: A61L15/44
Filed: 1999-02-05
Granted: 2010-07-07
Abstract: A mixed micellar pharmaceutical formulation includes a micellar proteinic pharmaceutical agent, an alkali metal C8 to C22 alkyl sulphate, alkali metal salicylate, a pharmaceutically acceptable edetate and at least one absorption enhancing compounds. The absorption enhancing compounds are selected from the group consisting of lecithin, hyaluronic acid, pharmaceutically acceptable salts of hyaluronic acid, octylphenoxypolyethoxyethanol, glycolic acid, lactic acid, chamomile extract, cucumber extract, oleic acid, linolenic acid, borage oil, evening of primrose oil, trihydroxy oxo cholanylglycine, glycerin, polyglycerin, lysine, polylysine, triolein and mixtures thereof. The amount of each absorption enhancing compound is present in a concentration of from 1 to 10 wt./wt. % of the total formulation, and the total concentration of absorption enhancing compounds are less than 50 wt./wt. % of the formulation.
Patent JP-4596645-B2 (JP)
IPC: B22F3/00
Filed: 1999-07-09
Granted: 2010-12-08
Abstract: Magnetic nanocomposite materials including iron, rare earth elements, boron, refractory metals and cobalt which have favorable magnetic properties and are suitable for making bonded magnets are disclosed. Compositions of the present invention can be of the formula: (N1-yLay)vFe100-v-w-x-zCowMzBx, where M is at least one refractory metal selected from Ti, Zr, Hf, V, Nb, Ta, Cr, Mo and W; v is from about 5 to about 15; w is greater than or equal to 5; x is from about 9 to about 30; y is from about 0.05 to about 0.5; and z is from about 0.1 to about 5. Preferably M is at least Cr. These materials have good magnetic properties and are suitable for use in preparing bonded magnets.
Patent JP-4467183-B2 (JP)
IPC: A47K10/32
Filed: 1999-08-11
Granted: 2010-05-26
Abstract: The invention relates to a paper dispenser, especially to a paper dispenser for moistening reel paper.
Patent JP-3803254-B2 (JP)
IPC: C07C51/235
Filed: 2000-04-05
Granted: 2006-08-02
Abstract: An acetic acid production catalyst that contains (b) at least one element selected from the group consisting of Group 14 elements, Group 15 elements and Group 16 elements of the Periodic Table and/or (c) at least one element selected from the group consisting of Group 6 elements, Group 7 elements, Group 8 elements, Group 9 elements, Group 10 elements, Group 11 elements and Group 12 elements of the Periodic Table, added to a palladium-loaded catalyst, as well as an acetic acid and ethyl acetate production catalyst that contains (b) at least one compound selected from the group consisting of inorganic acids and salts thereof and/or (c) at least one element selected from the group consisting of Group 14 elements, Group 15 elements and Group 16 elements of the Periodic Table and/or (d) at least one element selected from the group consisting of Group 6 elements, Group 7 elements, Group 8 elements, Group 9 elements, Group 10 elements, Group 11 elements and Group 12 elements of the Periodic Table, added to palladium.
Patent JP-4480902-B2 (JP)
IPC: A61B5/01
Filed: 2000-04-18
Granted: 2010-06-16
Abstract: Apparatus for recording a thermooptical image of the female breast with a casing, a thermooptical foil, a cooling box, a thermostat, an illuminating system, a digital camera, a clamping device, a contact producing device, a timing system and a release mechanism for automatic release of the digital camera.
Patent JP-3393124-B2 (JP)
IPC: C08L67/04
Filed: 2001-04-24
Granted: 2003-04-07
Abstract: This invention relates to binary blends of cellulose esters and aliphatic-aromatic copolyesters, cellulose esters and aliphatic polyesters as well as ternary blends of cellulose esters and/or aliphatic polyesters and/or aliphatic-aromatic copolyesters and/or polymeric compounds as well as fibers, molded objects, and films prepared therefrom.
Patent JP-4418136-B2 (JP)
IPC: H04W80/04
Filed: 2000-04-18
Granted: 2010-02-17
Abstract: A telecommunication system including a mobile station, and means for a mobile station to receive voice-over Internet Protocol (VoIP) calls when it is roaming away from a home network, comprising: means for informing a serving GGSN of the International Mobile subscriber Identity (IMSI) of the called mobile station, and means for enabling a local VoIP control server to map a called MSISDN number to the IMSI number.  <IMAGE>
Patent JP-4594577-B2 (JP)
IPC: C12Q1/689
Filed: 2001-01-22
Granted: 2010-12-08
Abstract: The present invention relates to a method of isolating cells from a sample which method comprises binding said cells to a solid support by means of a non-specific ligand immobilised on said solid support, particularly to a method of isolating microorganisms from a sample. Preferred ligands for use in such methods include carbohydrates and derivatives thereof. Also describe is a kit for isolating microorganisms from a sample comprising: 
(a) a solid support having immobilised thereon a ligand which is capable of non-specific binding to microorganisms; 
(b) means for binding microorganisms to said solid support; optionally 
(c) means for lysing said cells; and optionally 
(d) means for binding nucleic acid released from said lysed cells to a solid support.
Patent JP-3748536-B2 (JP)
IPC: C07D405/04
Filed: 2002-02-04
Granted: 2006-02-22
Abstract: The present invention provides crystalline forms of a pyrimidine nucleoside derivative having excellent anti-tumour activity. ÄSolutionÜ <??>Crystalline forms of compound of the following formula (I): <CHEM> <IMAGE>